Healthconn

Healthconn Financial Leverage

The Financial Leverage (Equity Multiplier) of Healthconn (6665.TWO) as of Oct 31, 2026 is 1.61. In the previous year, Financial Leverage (Equity Multiplier) was 1.61 — a change of 0.38% (higher).

Financial Leverage

1.61

YoY

0.38%

Last updated:

Financial Leverage (Equity Multiplier) of Healthconn is 2025 1.61 . Financial Leverage (Equity Multiplier) of Healthconn was 2024 1.61 . It decreases by 0.38% higher compared to the previous year.

The Healthconn Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.44 TWD
Jan 1, 2019
1.29 TWD
Jan 1, 2020
1.42 TWD
Jan 1, 2021
1.92 TWD
Jan 1, 2022
1.77 TWD
Jan 1, 2023
1.68 TWD
Jan 1, 2024
1.61 TWD
Jan 1, 2025
1.61 TWD
The Healthconn Financial Leverage history
YEARFinancial LeverageYoY
1.61+0.38%
1.61-4.37%
1.68-4.92%
1.77-8.22%
1.92+35.78%
1.42+10.26%
1.29-10.50%
1.44-3.96%
1.50+13.46%
1.32-10.82%
1.48+4.70%
1.41—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Healthconn Stock analysis

What does Healthconn do? Healthconn Corp offers tailored lifestyle optimization solutions across nutrition, exercise, stress management, and sleep. The company provides precisely prevent medical integration services, including precise prevention, disease management, and health promotion. Molecular biology testing programs cover food safety and functional medical testing, while accurate diagnostic testing services encompass molecular and clinical microbiological testing. Healthconn also develops and operates medical health institutions and sells medical equipment. Its primary markets are Taiwan and mainland China, serving clients seeking integrated health and medical solutions. The firm’s revenue streams include precisely prevent medical integration services, molecular biology testing programs, accurate diagnostic testing services, and medical equipment sales. Clients are individuals and organizations focused on preventive healthcare, wellness, and diagnostic accuracy. The company targets the Taiwan and mainland China markets, delivering comprehensive health services through its medical health institutions and testing programs. Healthconn Corp’s business model combines lifestyle optimization with medical services, leveraging molecular testing and diagnostic capabilities. By integrating prevention, disease management, and health promotion, it caters to clients prioritizing proactive health strategies. The medical equipment sales segment complements its service offerings, enhancing accessibility to health solutions in Taiwan and mainland China. Healthconn is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Healthconn stock

Financial Leverage (Equity Multiplier) of Healthconn is 1.61 in 2025.

Financial Leverage (Equity Multiplier) of Healthconn changed from 1.61 to 1.61, representing a 0.38% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Healthconn since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Healthconn with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Healthconn

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Healthconn